The European Medicines Agency (EMA) and its partners in the European medicines regulatory network have monitored the potential impact of the COVID-19 pandemic on the veterinary medicine supply chain in the European Union (EU).
Regulatory information on the impact of the COVID-19 pandemic on veterinary medicines is contained together with the information on human medicines. Please refer to the relevant content in the human regulatory section:
- Availability of medicines during COVID-19 pandemic
- Guidance for medicine developers and companies on COVID-19
Veterinary stakeholders have also been able to follow updates from EMA on COVID-19, including news and press releases: